| ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma (NCT04579523) | Fred Hutchinson Cancer Center | 2027-06-01 |
| Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer (NCT07667335) | Fred Hutchinson Cancer Center | 2026-12-01 |
| A Novel Smartphone Application for Helping Teens Stop Vaping, QuitQuest Vaping R01 (NCT07739706) | Fred Hutchinson Cancer Center | 2026-12-01 |
| Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study (NCT07737314) | Fred Hutchinson Cancer Center | 2026-11-01 |
| A Behavioral Application for Improving Smoking Cessation Among Smokers (NCT07493252) | Fred Hutchinson Cancer Center | 2026-11-01 |
| An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial (NCT07615764) | Fred Hutchinson Cancer Center | 2026-11-01 |
| TelePharm PrEP/PEP (NCT07561658) | Fred Hutchinson Cancer Center | 2026-10-01 |
| A Smartphone Application (QuitBot) for the Improvement of Smoking Cessation Among American Indians and Alaska Natives, NAITIVE Trial (NCT06697496) | Fred Hutchinson Cancer Center | 2026-09-30 |
| Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial (NCT07576725) | Fred Hutchinson Cancer Center | 2026-09-01 |
| A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial (NCT06771739) | Fred Hutchinson Cancer Center | 2026-09-01 |
| Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases (NCT07660783) | Fred Hutchinson Cancer Center | 2026-09-01 |
| FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia (NCT07645469) | Fred Hutchinson Cancer Center | 2026-09-01 |
| Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial (NCT06926062) | Fred Hutchinson Cancer Center | 2026-09-01 |
| Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT07194980) | Fred Hutchinson Cancer Center | 2026-09-01 |
| Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic Cancers (NCT07731880) | Fred Hutchinson Cancer Center | 2026-09-01 |
| Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms (NCT07094750) | Fred Hutchinson Cancer Center | 2026-09-01 |
| A Spiritual Health Intervention (PATH) for Improving Spiritual, Religious and Emotional Distress in Cancer Patients (NCT07545291) | Fred Hutchinson Cancer Center | 2026-09-01 |
| A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial (NCT07490860) | Fred Hutchinson Cancer Center | 2026-09-01 |
| Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Patients (NCT07390968) | Fred Hutchinson Cancer Center | 2026-09-01 |
| A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users (NCT06909500) | Fred Hutchinson Cancer Center | 2026-08-15 |
| Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial (NCT07176000) | Fred Hutchinson Cancer Center | 2026-08-15 |
| iCanQuit Smoking Cessation Among Hispanic Adults (NCT06811038) | Fred Hutchinson Cancer Center | 2026-08-15 |
| Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial (NCT06802172) | Fred Hutchinson Cancer Center | 2026-07-23 |
| Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer (NCT05874297) | Fred Hutchinson Cancer Center | 2026-07-15 |
| Effect of Meal Timing During Adjuvant Treatment for Cancer (NCT07524218) | Fred Hutchinson Cancer Center | 2026-07-06 |
| Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease (NCT07535008) | Fred Hutchinson Cancer Center | 2026-06-11 |
| A Novel Mobile Health Intervention for Improving Tobacco Cessation Among Young Adults (NCT07571018) | Fred Hutchinson Cancer Center | 2026-06-07 |
| Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa (NCT07645378) | Fred Hutchinson Cancer Center | 2026-06-01 |
| Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe (NCT07645352) | Fred Hutchinson Cancer Center | 2026-06-01 |
| Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda (NCT07390916) | Fred Hutchinson Cancer Center | 2026-05-31 |
| Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma (NCT07225985) | Fred Hutchinson Cancer Center | 2026-04-27 |
| Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person (NCT07141407) | Fred Hutchinson Cancer Center | 2026-04-08 |
| Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma (NCT07181941) | Fred Hutchinson Cancer Center | 2026-03-24 |
| Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya (NCT07468695) | Fred Hutchinson Cancer Center | 2026-03-01 |
| Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians (NCT07282158) | Fred Hutchinson Cancer Center | 2026-02-24 |
| Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes (NCT07228624) | Fred Hutchinson Cancer Center | 2026-02-04 |
| Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial (NCT06983899) | Fred Hutchinson Cancer Center | 2026-01-28 |
| Rifaximin Versus No Intervention for the Treatment of IgG/IgA (Non-IgM) Monoclonal Gammopathy of Undetermined Significance (NCT07209371) | Fred Hutchinson Cancer Center | 2026-01-22 |
| Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial (NCT07227571) | Fred Hutchinson Cancer Center | 2026-01-16 |
| ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma (NCT07098364) | Fred Hutchinson Cancer Center | 2025-12-27 |
| Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals (NCT06817889) | Fred Hutchinson Cancer Center | 2025-12-23 |
| A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial (NCT06822530) | Fred Hutchinson Cancer Center | 2025-12-16 |
| EQQUAL-NM for the Promotion of Smoking Cessation in Sexual and Gender Minority Young Adults in New Mexico (NCT06386432) | Fred Hutchinson Cancer Center | 2025-12-01 |
| Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education (NCT06995924) | Fred Hutchinson Cancer Center | 2025-11-17 |
| Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial (NCT07052630) | Fred Hutchinson Cancer Center | 2025-10-21 |
| Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer (NCT07046078) | Fred Hutchinson Cancer Center | 2025-09-26 |
| Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia (NCT06752694) | Fred Hutchinson Cancer Center | 2025-09-25 |
| Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse (NCT06928662) | Fred Hutchinson Cancer Center | 2025-09-23 |
| Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm (NCT06545344) | Fred Hutchinson Cancer Center | 2025-09-01 |
| Axatilimab for Sclerotic Chronic Graft-versus-Host Disease (NCT07011810) | Fred Hutchinson Cancer Center | 2025-08-06 |
| Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors (NCT05930496) | Fred Hutchinson Cancer Center | 2025-07-08 |
| A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial (NCT06145763) | Fred Hutchinson Cancer Center | 2025-07-03 |
| Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru (NCT07074899) | Fred Hutchinson Cancer Center | 2025-06-12 |
| Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma (NCT06839053) | Fred Hutchinson Cancer Center | 2025-06-02 |
| Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Survivors, MIND Trial (NCT06643455) | Fred Hutchinson Cancer Center | 2025-05-16 |
| Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer (NCT06094842) | Fred Hutchinson Cancer Center | 2025-04-15 |
| Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial (NCT05930483) | Fred Hutchinson Cancer Center | 2025-04-08 |
| Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy (NCT05936229) | Fred Hutchinson Cancer Center | 2025-04-01 |
| Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia (NCT06922188) | Fred Hutchinson Cancer Center | 2025-03-31 |
| Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL Trial (NCT06324110) | Fred Hutchinson Cancer Center | 2025-03-01 |
| Helping Ovarian Cancer Patients Cope With Their Illness (HOPE) (NCT06666218) | Fred Hutchinson Cancer Center | 2025-02-24 |
| FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT06609928) | Fred Hutchinson Cancer Center | 2025-02-24 |
| Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning (NCT04515810) | Fred Hutchinson Cancer Center | 2025-02-18 |
| Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer (NCT06236139) | Fred Hutchinson Cancer Center | 2024-11-26 |
| Improving Engagement in HIV and Cancer Care in Zimbabwe (NCT06934369) | Fred Hutchinson Cancer Center | 2024-11-18 |
| Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors (NCT06682039) | Fred Hutchinson Cancer Center | 2024-11-08 |
| A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant (NCT06559709) | Fred Hutchinson Cancer Center | 2024-10-14 |
| Cooking for Your Health in Southern New Mexico: an 8-week, Bilingual (English and Spanish) Nutritional Intervention in Adults Living in Doña Ana and Otero Counties (NCT06609057) | Fred Hutchinson Cancer Center | 2024-10-12 |
| DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse After Hematopoietic Cell Transplantation, the DR. DREAM Trial (NCT06492707) | Fred Hutchinson Cancer Center | 2024-09-23 |
| Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials (NCT06484595) | Fred Hutchinson Cancer Center | 2024-09-23 |
| Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer (NCT06145633) | Fred Hutchinson Cancer Center | 2024-09-18 |
| Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases (NCT06013423) | Fred Hutchinson Cancer Center | 2024-07-23 |
| High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial (NCT06298734) | Fred Hutchinson Cancer Center | 2024-07-01 |
| Expanding Clinical Trial Awareness Among Black Communities Through Digital Engagement (NCT06218615) | Fred Hutchinson Cancer Center | 2024-06-06 |
| Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer (NCT05564468) | Fred Hutchinson Cancer Center | 2024-05-21 |
| An Escape Room Intervention to Help Improve Breast Cancer Patients' Ability to Navigate Online Access to Nutrition Information (NCT06193070) | Fred Hutchinson Cancer Center | 2024-03-07 |
| Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacies (NCT05831540) | Fred Hutchinson Cancer Center | 2024-02-28 |
| Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma (NCT04466475) | Fred Hutchinson Cancer Center | 2024-01-27 |
| H-PACE Program for the Improvement of Lifestyle Behaviors Among Children (NCT06548074) | Fred Hutchinson Cancer Center | 2024-01-22 |
| A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults (NCT05897242) | Fred Hutchinson Cancer Center | 2024-01-04 |
| Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial (NCT05918263) | Fred Hutchinson Cancer Center | 2024-01-01 |
| Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms (NCT06034470) | Fred Hutchinson Cancer Center | 2023-12-18 |
| Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations (NCT06043713) | Fred Hutchinson Cancer Center | 2023-12-15 |
| Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation (NCT06026371) | Fred Hutchinson Cancer Center | 2023-12-12 |
| Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease (NCT05996627) | Fred Hutchinson Cancer Center | 2023-12-06 |
| Avatar-Led Digital Therapeutic for Aiding Smoking Cessation in Sexual and Gender Minority Young Adults (NCT05847673) | Fred Hutchinson Cancer Center | 2023-08-20 |
| Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia (NCT04994808) | Fred Hutchinson Cancer Center | 2023-08-11 |
| Pharmacy-based PrEP Delivery in Kenya (NCT05842122) | Fred Hutchinson Cancer Center | 2023-06-20 |
| Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial (NCT04941716) | Fred Hutchinson Cancer Center | 2023-05-31 |
| A Video Intervention to Decrease Patient Fear of Colonoscopy After a Positive Fecal Immunochemical Test (NCT05458986) | Fred Hutchinson Cancer Center | 2023-05-15 |
| Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma (NCT05228249) | Fred Hutchinson Cancer Center | 2023-04-01 |
| NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma (NCT05359211) | Fred Hutchinson Cancer Center | 2022-12-08 |
| Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines (NCT05592223) | Fred Hutchinson Cancer Center | 2022-12-06 |
| Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic (NCT05556772) | Fred Hutchinson Cancer Center | 2022-11-14 |
| Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study (NCT04593277) | Fred Hutchinson Cancer Center | 2022-10-23 |
| A Multilevel Approach for Improvement in Screening of Colorectal Cancer in Rural Communities, The Screen to Save Trial (NCT05291988) | Fred Hutchinson Cancer Center | 2022-10-08 |
| Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers (NCT04083170) | Fred Hutchinson Cancer Center | 2022-10-06 |
| An Innovative Conversational Agent (Quitbot) for Smoking Cessation (NCT04308759) | Fred Hutchinson Cancer Center | 2022-07-24 |
| Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies (NCT04829136) | Fred Hutchinson Cancer Center | 2022-06-22 |
| Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer (NCT05098210) | Fred Hutchinson Cancer Center | 2022-06-09 |